PTBP3 Mediates IL‐18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer

Bibliographic Details
Title: PTBP3 Mediates IL‐18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer
Authors: Cheng Zhao, Jing‐wei Zhao, Yu‐han Zhang, Yi‐di Zhu, Zi‐yi Yang, Shi‐lei Liu, Qiu‐yi Tang, Yue Yang, Hua‐kai Wang, Yi‐jun Shu, Ping Dong, Xiang‐song Wu, Wei Gong
Source: Advanced Science, Vol 11, Iss 38, Pp n/a-n/a (2024)
Publisher Information: Wiley, 2024.
Publication Year: 2024
Collection: LCC:Science
Subject Terms: alternative splicing, gallbladder cancer, IL‐18, immune escape, PTBP3, Science
More Details: Abstract Gallbladder cancer (GBC) is the most common malignant tumor of the biliary system, with poor response to current treatments. Abnormal alternative splicing has been associated with the development of a variety of tumors. Combining the GEO database and GBC mRNA‐seq analysis, it is found high expression of the splicing factor polypyrimidine region‐ binding protein 3 (PTBP3) in GBC. Multi‐omics analysis revealed that PTBP3 promoted exon skipping of interleukin‐18 (IL‐18), resulting in the expression of ΔIL‐18, an isoform specifically expressed in tumors. That ΔIL‐18 promotes GBC immune escape by down‐regulating FBXO38 transcription levels in CD8+T cells to reduce PD‐1 ubiquitin‐mediated degradation is revealed. Using a HuPBMC mouse model, the role of PTBP3 and ΔIL‐18 in promoting GBC growth is confirmed, and showed that an antisense oligonucleotide that blocked ΔIL‐18 production displayed anti‐tumor activity. Furthermore, that the H3K36me3 promotes exon skipping of IL‐18 by recruiting PTBP3 via MRG15 is demonstrated, thereby coupling the processes of IL‐18 transcription and alternative splicing. Interestingly, it is also found that the H3K36 methyltransferase SETD2 binds to hnRNPL, thereby interfering with PTBP3 binding to IL‐18 pre‐mRNA. Overall, this study provides new insights into how aberrant alternative splicing mechanisms affect immune escape, and provides potential new perspectives for improving GBC immunotherapy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2198-3844
Relation: https://doaj.org/toc/2198-3844
DOI: 10.1002/advs.202406633
Access URL: https://doaj.org/article/9f6490bd73494ed69d04c7273098551a
Accession Number: edsdoj.9f6490bd73494ed69d04c7273098551a
Database: Directory of Open Access Journals
More Details
ISSN:21983844
DOI:10.1002/advs.202406633
Published in:Advanced Science
Language:English